Article
Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo.
Cell transplantation - 1 Jan 2016
Thewissen Kristof, Broux Bieke, Hendriks Jerome J A, Vanhees Mandy, Stinissen Piet, Slaets Helena, Hellings Niels
Abstract excerpt
The aim of this study is to examine whether the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), can generate dendritic cells (DCs) with a stable tolerogenic phenotype to counteract autoimmune responses in an animal model of multiple sclerosis. We investigated if the tolerogenic potency of DCs could be increased by continuous treatment during in vitro differentiation toward DCs compared to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
